These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8028032)

  • 1. Prostate cancer genetics research picks up pace.
    Reynolds T
    J Natl Cancer Inst; 1994 Aug; 86(15):1112-5. PubMed ID: 8028032
    [No Abstract]   [Full Text] [Related]  

  • 2. Downregulated Krüppel‑like factor 4 expression is associated with the aggressiveness of prostate cancer.
    Zhang N; Su P; Li X; Xi J; Li X; Xu L
    Oncol Rep; 2019 Mar; 41(3):1789-1796. PubMed ID: 30747213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells.
    Tsui KH; Feng TH; Lin YF; Chang PL; Juang HH
    Prostate; 2011 Jan; 71(1):62-70. PubMed ID: 20607720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
    Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
    Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53.
    Mashimo T; Watabe M; Hirota S; Hosobe S; Miura K; Tegtmeyer PJ; Rinker-Shaeffer CW; Watabe K
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11307-11. PubMed ID: 9736732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.
    Chen X; Cheng H; Pan T; Liu Y; Su Y; Ren C; Huang D; Zha X; Liang C
    Mol Carcinog; 2015 Oct; 54(10):1086-95. PubMed ID: 25043657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DU145 human prostate carcinoma cell line harbors a temperature-sensitive allele of p53.
    Bajgelman MC; Strauss BE
    Prostate; 2006 Sep; 66(13):1455-62. PubMed ID: 16741917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
    Roger L; Jullien L; Gire V; Roux P
    J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer.
    Zhang H; Melamed J; Wei P; Cox K; Frankel W; Bahnson RR; Robinson N; Pyka R; Liu Y; Zheng P
    Cancer Immun; 2003 Feb; 3():2. PubMed ID: 12747744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical determination of p53 protein in prostatic cancer and prostatic intraepithelial neoplasms.
    Yaman O; Ozdiler E; Orhan D; Sak SD; Baltaci S; Tulunay O; Göğüş O
    Urol Int; 1997; 58(4):199-202. PubMed ID: 9253117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma.
    Li Z; Sun Y; Chen X; Squires J; Nowroozizadeh B; Liang C; Huang J
    Mol Cancer Res; 2015 Mar; 13(3):584-91. PubMed ID: 25512615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis?
    Roy-Burman P; Zheng J; Miller GJ
    Mol Med Today; 1997 Nov; 3(11):476-82. PubMed ID: 9430782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer.
    Pascal LE; Wang Y; Zhong M; Wang D; Chakka AB; Yang Z; Li F; Song Q; Rigatti LH; Chaparala S; Chandran U; Parwani AV; Wang Z
    Neoplasia; 2018 Apr; 20(4):351-363. PubMed ID: 29518696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of expression profiling of circulating microRNAs in men with prostate cancer.
    Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
    BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
    Duan H; Zhang HJ; Yang JQ; Oberley LW; Futscher BW; Domann FE
    Antioxid Redox Signal; 2003 Oct; 5(5):677-88. PubMed ID: 14580325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
    Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ
    Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors.
    Chaib H; MacDonald JW; Vessella RL; Washburn JG; Quinn JE; Odman A; Rubin MA; Macoska JA
    Genes Chromosomes Cancer; 2003 Jul; 37(3):306-13. PubMed ID: 12759929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.